The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Struthers Richard Scott since 2019.
This trader's CIK number is 1746298.
At the time of last reporting, Struthers Richard Scott was the President & CEO of Crinetics Pharmaceuticals, Inc.. (stock ticker symbol CRNX).
Also see all insider trading activities at Crinetics Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CRNX | 0 | $0 | 17,338 | $598,161 | 81,270 | $155,225 |
| 2024 | CRNX | 0 | $0 | 158,399 | $7,897,191 | 168,399 | $1,415,342 |
| 2023 | CRNX | 0 | $0 | 300,000 | $8,162,253 | 260,000 | $1,970,599 |
| 2022 | CRNX | 0 | $0 | 160,000 | $4,214,159 | 11,100 | $21,201 |
| 2021 | CRNX | 0 | $0 | 30,000 | $750,000 | 0 | $0 |
| 2020 | CRNX | 5,000 | $65,000 | 35,000 | $520,817 | 0 | $0 |
| 2019 | CRNX | 0 | $0 | 0 | $0 | 10,000 | $19,100 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-02 | CRNX | Option Ex | 81,270 | 1.91 | 155,225 |
| 2025-03-19 | CRNX | Sale | 17,338 | 34.50 | 598,161 |
| 2024-12-02 | CRNX | Sale | 10,000 | 57.57 | 575,700 |
| 2024-05-08 | CRNX | Option Ex | 107,448 | 9.28 | 997,117 |
| 2024-05-08 | CRNX | Sale | 107,448 | 49.40 | 5,307,931 |
| 2024-04-15 | CRNX | Option Ex | 20,000 | 1.91 | 38,200 |
| 2024-04-04 | CRNX | Sale | 40,951 | 49.17 | 2,013,560 |
| 2024-04-04 | CRNX | Option Ex | 40,951 | 9.28 | 380,025 |
| 2023-11-09 | CRNX | Option Ex | 50,000 | 1.91 | 95,500 |
| 2023-11-02 | CRNX | Option Ex | 918 | 9.28 | 8,519 |
| 2023-11-03 | CRNX | Option Ex | 199,082 | 9.28 | 1,847,480 |
| 2023-11-02 | CRNX | Sale | 918 | 29.95 | 27,494 |
| 2023-11-03 | CRNX | Sale | 199,082 | 30.56 | 6,083,945 |
| 2023-08-14 | CRNX | Option Ex | 10,000 | 1.91 | 19,100 |
| 2023-07-11 | CRNX | Sale | 24,384 | 20.14 | 491,093 |
| 2023-07-12 | CRNX | Sale | 11,459 | 20.17 | 231,128 |
| 2023-07-13 | CRNX | Sale | 14,157 | 20.35 | 288,094 |
| 2023-06-16 | CRNX | Sale | 50,000 | 20.81 | 1,040,499 |
| 2022-10-12 | CRNX | Option Ex | 11,100 | 1.91 | 21,201 |
| 2022-04-13 | CRNX | Sale | 138,643 | 26.49 | 3,672,930 |
| 2022-04-05 | CRNX | Sale | 21,357 | 25.34 | 541,229 |
| 2021-09-07 | CRNX | Sale | 30,000 | 25.00 | 750,000 |
| 2020-12-02 | CRNX | Buy | 1,000 | 12.60 | 12,600 |
| 2020-12-03 | CRNX | Buy | 4,000 | 13.10 | 52,400 |
| 2020-07-15 | CRNX | Sale | 17,500 | 15.30 | 267,715 |
| 2020-07-16 | CRNX | Sale | 17,500 | 14.46 | 253,102 |
| 2019-08-05 | CRNX | Option Ex | 10,000 | 1.91 | 19,100 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Struthers Richard Scott (President & CEO of Crinetics Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.